Advertisement
Screener

Jazz Pharmaceuticals plc (JAZZ) Finance Leases: Finance Lease, Liability

Jazz Pharmaceuticals plc Finance Lease, Liability

Jazz Pharmaceuticals plc (JAZZ) had Finance Lease, Liability of $3.88 million as of 2025-12-31, per its 10-K filed 2026-02-24.

Financial Statements › Balance Sheet › Liabilities › Debt

us-gaap:FinanceLeaseLiability · last filed 2026-02-24

  • 2025-12-31: Finance Lease, Liability $3.88M.
  • 2024-12-31: Finance Lease, Liability $5.01M.
  • 2023-12-31: Finance Lease, Liability $5.47M.
  • 2022-12-31: Finance Lease, Liability $5.59M.
Period endFinance Lease, Liability
2025-12-31$3.88M
10-K · filed 2026-02-24
2024-12-31$5.01M
10-K · filed 2025-02-26
2023-12-31$5.47M
10-K · filed 2024-02-28
2022-12-31$5.59M
10-K · filed 2023-03-01
2021-12-31$6.67M
10-K · filed 2022-03-01
2021-09-30$6.76M
10-Q · filed 2021-11-09
2021-06-30$6.40M
10-Q · filed 2021-08-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
Viatris Inc (VTRS)United States$20.008B-0.00
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28